RAYMOND JAMES & ASSOCIATES - SURFACE ONCOLOGY INC ownership

SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 108 filers reported holding SURFACE ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of SURFACE ONCOLOGY INC
ValueSharesWeighting
Q4 2021$88,000
-84.5%
18,393
-75.4%
0.00%
-100.0%
Q3 2021$567,000
-28.4%
74,898
-29.5%
0.00%0.0%
Q2 2021$792,000
+3.1%
106,203
+7.8%
0.00%0.0%
Q1 2021$768,000
+97.9%
98,511
+134.3%
0.00%
Q4 2020$388,000
-36.1%
42,037
-52.3%
0.00%
-100.0%
Q3 2020$607,00088,0390.00%
Other shareholders
SURFACE ONCOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 2,945,453$21,972,0003.87%
ACT CAPITAL MANAGEMENT, LLC 170,500$1,272,0000.65%
Parkman Healthcare Partners LLC 228,267$1,703,0000.37%
SILVERARC CAPITAL MANAGEMENT, LLC 94,539$705,0000.31%
C M BIDWELL & ASSOCIATES LTD 33,030$246,0000.16%
GSA CAPITAL PARTNERS LLP 115,147$859,0000.10%
Knights of Columbus Asset Advisors LLC 113,594$847,0000.08%
ARK Investment Management 4,478,546$33,410,0000.06%
Ipswich Investment Management Co., Inc. 32,000$239,0000.06%
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 27,400$204,0000.04%
View complete list of SURFACE ONCOLOGY INC shareholders